• 제목/요약/키워드: Korean Oncology

검색결과 6,315건 처리시간 0.038초

Abdomen Immobilization with Air Injected Balloon Blanket

  • Suh, Ye-Lin;Yi, Byong-Yong;Ahn, Seung-Do;Lee, Sang-Wook;Kim, Jong-Hoon;Shin, Seung-Ai;Park, Eun-Kyung
    • 한국의학물리학회:학술대회논문집
    • /
    • 한국의학물리학회 2002년도 Proceedings
    • /
    • pp.100-102
    • /
    • 2002
  • The demand for a better immobilization device has been increased in the radiation oncology field. Especially, it is essential to have a reliable and practical immobilization tool for the whole body radiosurgery and the IMRT (intensity modulated radiation therapy). A useful method to immobilize the abdomen for the external beam radiation treatment is developed. The air-injected balloon blanket (AIBB) was designed as an immobilization device. As the air was injected into it, it pressed down the patient's abdomen and fixed the patient. The AIBB played a role not only to grab the patients' motion, but also to increase the patients' setup reproducibility. Patients' movements due to the respiration were reduced and the reconstruction could be maximized. The experimental results revealed that the AIBB could be used for the clinic.

  • PDF

종양간호사와 일반간호사의 흡연 중재 비교 조사 연구 (A Comparison on the Tobacco Control Intervention, Barriers, and Facilitators between Oncology Nurses and General Nurses in Clinical Practice)

  • 오복자;신성례
    • 성인간호학회지
    • /
    • 제17권4호
    • /
    • pp.529-538
    • /
    • 2005
  • Purpose: This study was conducted to 1) find out the frequency of tobacco control intervention, barriers, and facilitators. 2) compare the differences in tobacco control intervention, barriers, and facilitators between oncology nurses and general nurses. Method: A sample was composed of 96 oncology nurses and 284 general nurses. The survey questionnaire was mailed out to nurses who were working at the randomly selected hospitals throughout the country. The questionnaire was adopted from the study of national survey on oncology nurse's tobacco interventions in United States by Sarnar, et al.(2000). Results: Oncology nurses were found to provide tobacco control interventions more frequently comparing to the general nurses. "Patient not motivated to quit smoking", "Lack of time", "Lack of recognition/rewards", were the most commonly identified barriers. "Patient wants to quit", "Adequate time", "Confidence in ability help people to stop smoking", were the most commonly identified facilitators. Conclusions: Although oncology nurses are in an important position in delivering tobacco interventions and providing resources, their participation in consistent delivery of a tobacco control intervention was less than desirable. To help nurses participate in the assessment of tobacco use and interventions for cessation, the development of educational program is necessary.

  • PDF

2019 미국 임상종양학회 두경부암 하이라이트 (Highlights for the 2019 American Society of Clinical Oncology (ASCO) Annual Meeting)

  • 이윤규
    • 대한두경부종양학회지
    • /
    • 제35권2호
    • /
    • pp.1-10
    • /
    • 2019
  • The 2019 American Society of Clinical Oncology (ASCO) Annual Meeting, which took place May 31-June 4 in Chicago, drew more than 32,000 oncology specialists from around the world. The theme of 2019 ASCO conference was "Caring for Every Patient, Learning from Every Patient". Among the topics of interest covered were new approaches to surmount limited access to cancer care and the latest advances in targeted therapies for pancreatic, prostate cancers and soft tissue sarcomas. In the field of head and neck cancer, 8 oral abstracts and 75 poster abstracts were presented at this meeting. In this review, we are going to summarize the eight studies that have been presented orally. The topics are recurrent and/or metastatic head and neck squamous cell carcinoma for two abstracts (#6000, #6002), salivary duct carcinoma for one abstract (#6001), locally advanced nasopharyngeal carcinoma for two abstracts (#6003, #6004), oropharyngeal carcinoma for two abstracts (#6006, #6008), and oral cavity cancer for one abstract (#6007).

항암화학요법을 받는 부인암 환자의 외상 후 성장 영향 요인 (Factors Influencing Posttraumatic Growth of Gynecologic Oncology Patients Undergoing Chemotherapy)

  • 윤선정;김혜영
    • 여성건강간호학회지
    • /
    • 제25권4호
    • /
    • pp.409-422
    • /
    • 2019
  • Purpose: The purpose of this study was to investigate the factors impacting the posttraumatic growth (PTG) factors during chemotherapy in gynecologic oncology patients. Method: The data were collected at six hospitals at a university hospital, general hospital, women's hospital, and 3 oncology hospitals in D metropolitan city. The participants of the study were 135 female patients undergoing chemotherapy for their gynecologic oncology. To identify the factors that influence PTG, we used the questionnaires for the family support, sexual distress, health promoting behavior, and PTG. Results: There was a significant positive correlation between family support and health promoting behavior and PTG. There was significant negative correlation between sexual distress and PTG. Factors impacting the PTG of gynecologic oncology women undergoing chemotherapy were age, recurrence, family support, sexual distress, and health promoting behavior. These factors accounted for 47.0% of PTG. Conclusion: It is necessary to develop and apply programs that include sexual distress management education, and health promotion with families. PTG programs for gynecologic oncology patients undergoing chemotherapy should be approached considering these results.

직장암 치료에 있어 방사선 치료의 역할 (The Role of Radiotherapy in Management of Rectal Cancer)

  • 노준규;이창걸;성진실;김수곤;박경란;서창옥;김귀언
    • Radiation Oncology Journal
    • /
    • 제6권2호
    • /
    • pp.235-246
    • /
    • 1988
  • A total of 93 patients with rectal cancer treated with radiotherapy at department of Radiation Oncology, Yonsei University College of Medicine, Yonsei Cancer Center between January 1974 and December 1983 are retrospectively analysed. The patients are divided into three groups as follows: I. Postoperative radiotherapy, II. Postoperative recurrent, III. Unresectable or Inoperable group. In postoperative radiotherapy group, overall 5 year survival rate is $34.8\%$ and prognostic factors are presence of obstruction and degree of differentiation. In postoperative recurrent group, overall 2 year survival rate is $7.4\%$ with median survival of 13 months and prognostic factors are RT responsiveness and sex, and the local failure rate is $22.7\%$. In unresectable or inoperable group, overall 2 year survival rate is $19.8\%$ with median survival of 12.6 months and prognostic factors are RT responsiveness and RT dose. The complications for RT are not significant and are acceptable in all patients.

  • PDF

Short-course palliative radiotherapy for uterine cervical cancer

  • Kim, Dong Hyun;Lee, Ju Hye;Ki, Yong Kan;Nam, Ji Ho;Kim, Won Taek;Jeon, Ho Sang;Park, Dahl;Kim, Dong Won
    • Radiation Oncology Journal
    • /
    • 제31권4호
    • /
    • pp.216-221
    • /
    • 2013
  • Purpose: The purpose of this retrospective study was to evaluate the efficacy and feasibility of short-course hypofractionated radiotherapy (RT) for the palliation of uterine cervical cancer. Materials and Methods: Seventeen patients with cancer of the uterine cervix, who underwent palliative hypofractionated 3-dimensional conformal radiotherapy between January 2002 and June 2012, were retrospectively analyzed. RT was delivered to symptomatic lesions (both the primary mass and/or metastatic regional lymph nodes). The total dose was 20 to 25 Gy (median, 25 Gy) in 5 Gy daily fractions. Results: The median follow-up duration was 12.2 months (range, 4 to 24 months). The median survival time was 7.8 months (range, 4 to 24 months). Vaginal bleeding was the most common presenting symptom followed by pelvic pain (9 patients). The overall response rates were 93.8% and 66.7% for vaginal bleeding control and pelvic pain, respectively. Nine patients did not have any acute side effects and 7 patients showed minor gastrointestinal toxicity. Only 1 patient had grade 3 diarrhea 1 week after completion of treatment, which was successfully treated conservatively. Late complications occurred in 4 patients; however, none of these were of grade 3 or higher severity. Conclusion: Short-course hypofractionated RT was effective and well tolerated as palliative treatment for uterine cervical cancer.